Antioxidants reduce cellular and functional changes induced by intense noise in the inner ear and cochlear nucleus.
The present study marks the first evaluation of combined application of the antioxidant N-acetylcysteine (NAC) and the free radical spin trap reagent, disodium 2,4-disulfophenyl-N-tert-butylnitrone (HPN-07), as a therapeutic approach for noise-induced hearing loss (NIHL). Pharmacokinetic studies and C-14 tracer experiments demonstrated that both compounds achieve high blood levels within 30 min after i.p injection, with sustained levels of radiolabeled cysteine (released from NAC) in the cochlea, brainstem, and auditory cortex for up to 48 h. Rats exposed to 115 dB octave-band noise (10-20 kHz) for 1 h were treated with combined NAC/HPN-07 beginning 1 h after noise exposure and for two consecutive days. Auditory brainstem responses (ABR) showed that treatment substantially reduced the degree of threshold shift across all test frequencies (2-16 kHz), beginning at 24 h after noise exposure and continuing for up to 21 days. Reduced distortion product otoacoustic emission (DPOAE) level shifts were also detected at 7 and 21 days following noise exposure in treated animals. Noise-induced hair cell (HC) loss, which was localized to the basal half of the cochlea, was reduced in treated animals by 85 and 64% in the outer and inner HC regions, respectively. Treatment also significantly reduced an increase in c-fos-positive neuronal cells in the cochlear nucleus following noise exposure. However, no detectable spiral ganglion neuron loss was observed after noise exposure. The results reported herein demonstrate that the NAC/HPN-07 combination is a promising pharmacological treatment of NIHL that reduces both temporary and permanent threshold shifts after intense noise exposure and acts to protect cochlear sensory cells, and potentially afferent neurites, from the damaging effects of acoustic trauma. In addition, the drugs were shown to reduce aberrant activation of neurons in the central auditory regions of the brain following noise exposure. It is likely that the protective mechanisms are related to preservation of structural components of the cochlea and blocking the activation of immediate early genes in the auditory centers of the brain.
Hough Ear Institute, 3400 N.W. 56th Street, Oklahoma City, OK, 73112, USA, jlu@houghear.org.
Jianzhong
J
Lu
Wei
W
Li
Xiaoping
X
Du
Donald L
DL
Ewert
Matthew B
MB
West
Charles
C
Stewart
Robert A
RA
Floyd
Richard D
RD
Kopke
D000111:Acetylcysteine / Q000493:pharmacokinetics / Q000494:pharmacology*; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001557:Benzenesulfonates / Q000493:pharmacokinetics / Q000494:pharmacology*; D017626:Cochlear Nucleus / Q000187:drug effects* / Q000473:pathology / Q000502:physiology; D007758:Ear, Inner / Q000187:drug effects* / Q000473:pathology / Q000502:physiology; D016057:Evoked Potentials, Auditory, Brain Stem / Q000187:drug effects; D006198:Hair Cells, Auditory / Q000187:drug effects; D006317:Hearing Loss, Noise-Induced / Q000188:drug therapy*; D008297:Male; D018696:Neuroprotective Agents / Q000494:pharmacology*; D009622:Noise / Q000009:adverse effects*; D017084:Otoacoustic Emissions, Spontaneous / Q000187:drug effects; D016760:Proto-Oncogene Proteins c-fos / Q000032:analysis; D051381:Rats; D020318:Rats, Long-Evans; D019097:Spin Trapping; D013136:Spiral Ganglion / Q000473:pathology
D000975:Antioxidants; D001557:Benzenesulfonates; D018696:Neuroprotective Agents; D016760:Proto-Oncogene Proteins c-fos; C120851:disufenton sodium; D000111:Acetylcysteine